Products and Education designed to minimize risk and maximize outcomes
LIMERICK, Pa., Oct 15, 2010 (BUSINESS WIRE) --
Teleflex Incorporated, a proud Industry Supporter of the American
Society of Anesthesiologists, will showcase a number of anesthesia
products designed to help providers minimize risk and maximize outcomes
for their patients at the annual ASA meeting to be held in San Diego,
California on October 16-20, 2010. These products include:
- StimuCath(R) Safety Kits: StimuCath Safety Kits are designed to
help facilities be more compliant with OSHA and JCAHO guidelines by
including Sharps Safety Glide injection needles, locking Sharps Away
II cup and medication labels combined with StimuCath, the #1 selling
stimulating peripheral nerve block catheter in North America.
StimuCath's wire-coil helix allows for accurate placement of block
using stimulation and/or ultrasound. This unique catheter aids in
improving block success by allowing physicians to confirm catheter
location before, during and after placement.
- Arrow(R) FlexTip Plus(R) Epidural Catheter: With its unique
wire-embedded polyurethane design, the FlexTip Plus is the only
epidural catheter clinically proven to virtually eliminate the
incidence of intravascular cannulation1,2,3 and effectively
reduce transient paresthesia.4
- Arrow SureBlock(TM) Spinal Anesthesia Trays: Safety-engineered in
compliance with the latest guidelines from OSHA and JCAHO, SureBlock
trays feature the Sprotte(R) Spinal Needle. The Sprotte Spinal Needle,
with its special polished finish, has been clinically proven to
significantly reduce postdural puncture headaches.5, 6, 7, 8
Educational Opportunities
Teleflex is dedicated to supporting physicians and advancing the
practice of regional anesthesia through its clinical education program.
At the ASA meeting, Teleflex will host up to 200 physicians at a
Corporate non-CME Educational Update Dinner Symposium: Peripheral Nerve
Blocks in Surgery--Improving Patient Outcomes. The highly distinguished
physician panel includes Dr. Andre Boezaart, Dr. Krishna Boddu and Dr.
Loran Mounir Soliman.
Additionally, Teleflex has partnered with several facilities throughout
the United States to allow physicians to observe all aspects of
establishing and running peripheral nerve block and acute pain
management programs. Teleflex also sponsors a Pain Management Center of
Excellence, which allows physicians to gain hands-on peripheral nerve
block training at a world-class teaching institution.
All of these educational programs provide training on Teleflex's Arrow
brand of regional anesthesia products.
"We look forward to presenting and meeting customers at ASA as we build
on our efforts to support physicians with products and education to
address the concerns anesthesiologists face daily," said Cary Vance,
Executive Vice President, Teleflex, North America. "As we make our debut
as a newly-selected Industry Supporter for ASA at this year's
conference, we are pleased to continue to work with the anesthesia
industry as a trusted resource and partner."
For more information on the Teleflex's anesthesia products and
educational programs, visit www.teleflex.com.
About Teleflex Incorporated
Teleflex Incorporated (NYSE: TFX) is a global provider of medical
technology products that enable healthcare providers to improve patient
outcomes, reduce infections and support patient and provider safety.
Teleflex, which employs approximately 12,600 people worldwide, also has
niche businesses that serve segments of the aerospace and commercial
markets with specialty engineered products. Additional information about
Teleflex can be obtained from the company's website at www.teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Arrow, Sharps Away II, StimuCath, SureBlock and FlexTip Plus are
trademarks or registered trademarks of Teleflex Incorporated or its
affiliates. SafetyGlide is a registered trademark of Becton, Dickinson
and Company. Sprotte is a registered trademark of Pajunk GmbH LTD.
1. Mhyre, Jill M., et al. A Systematic Review of Randomized Controlled
Trials That Evaluate Strategies to Avoid Epidural Vein Cannulation
During Obstetric Epidural Catheter Placement. Anesthesia & Analgesia
2009; 108 (4): 1232-1242.
2. Banwell B.R., et al. Decreased incidence of complications in patients
with the Arrow (FlexTip Plus(TM)) epidural catheter. Canadian Journal of
Anaesthesia 1998; 45 (4): 370-372.
3. Cohen S., et al. Sutured Epidural Catheter for Epidural Block in
obstetric Patients: "Arrow" versus "B. Braun". Anesthesiology 2006;105:
A904.
4. Cohen S., et al. Arrow versus B. Braun Epidural Catheter for Epidural
Block in Obstetric Patients. Anesthesiology 2004; 101: A1199.
5. Toyka KV, Müller B, Reichmann H, Strupp M, Schüler O, Brandt T.
"Atraumatic" Sprotte needle reduces the incidence of post-lumbar
puncture headaches. Neurology 2002; 59: 1120-21.
6. Pittoni G, Toffoletto F, Calcarella G, Zanette G, Giron GP. Spinal
anesthesia in outpatient knee surgery: 22-gauge versus 25-gauge Sprotte
needle. Anesth. Analg. 1995; 81: 73-9.
7. Pajunk Sprotte cannula product brochure
8. Jäger H, Schimrigk K, Haab A. Post lumbar puncture headache
prevention by means of an atraumatic needle. Akt Neurol. 1991;
18:61-4.
SOURCE: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Vice President Investor Relations
610-948-2836